It is noteworthy that many patients with COVID-19 (e.g., those with severe disease) commonly display the same pathological phenotypes, namely lung inflammation, fibrosis, and pneumonia, linked to those ACE2-co-expressed genes. This evidence concerns the gene ACE2 and inflammatory response.